ChromoEnhancer: An Artificial-Intelligence-Based Tool to Enhance Neoplastic Karyograms as an Aid for Effective Analysis.
CycleGAN
chromosome
cytogenetics
enhancement
karyogram
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
20 07 2022
20 07 2022
Historique:
received:
04
04
2022
revised:
21
04
2022
accepted:
28
04
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
Cytogenetics laboratory tests are among the most important procedures for the diagnosis of genetic diseases, especially in the area of hematological malignancies. Manual chromosomal karyotyping methods are time consuming and labor intensive and, hence, expensive. Therefore, to alleviate the process of analysis, several attempts have been made to enhance karyograms. The current chromosomal image enhancement is based on classical image processing. This approach has its limitations, one of which is that it has a mandatory application to all chromosomes, where customized application to each chromosome is ideal. Moreover, each chromosome needs a different level of enhancement, depending on whether a given area is from the chromosome itself or it is just an artifact from staining. The analysis of poor-quality karyograms, which is a difficulty faced often in preparations from cancer samples, is time consuming and might result in missing the abnormality or difficulty in reporting the exact breakpoint within the chromosome. We developed ChromoEnhancer, a novel artificial-intelligence-based method to enhance neoplastic karyogram images. The method is based on Generative Adversarial Networks (GANs) with a data-centric approach. GANs are known for the conversion of one image domain to another. We used GANs to convert poor-quality karyograms into good-quality images. Our method of karyogram enhancement led to robust routine cytogenetic analysis and, therefore, to accurate detection of cryptic chromosomal abnormalities. To evaluate ChromoEnahancer, we randomly assigned a subset of the enhanced images and their corresponding original (unenhanced) images to two independent cytogeneticists to measure the karyogram quality and the elapsed time to complete the analysis, using four rating criteria, each scaled from 1 to 5. Furthermore, we compared the enhanced images with our method to the original ones, using quantitative measures (PSNR and SSIM metrics).
Identifiants
pubmed: 35883687
pii: cells11142244
doi: 10.3390/cells11142244
pmc: PMC9324748
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Med Radiat Sci. 2021 Jun;68(2):139-148
pubmed: 33169922
J Glob Health. 2019 Dec;9(2):010318
pubmed: 31788229
Annu Rev Genomics Hum Genet. 2006;7:315-38
pubmed: 16824019
Nat Rev Genet. 2015 Jun;16(6):321-32
pubmed: 25948244
Ann Lab Med. 2014 Nov;34(6):413-25
pubmed: 25368816
J Vis Exp. 2014 Jan 28;(83):e50203
pubmed: 24513647
Annu Int Conf IEEE Eng Med Biol Soc. 2012;2012:4438-41
pubmed: 23366912
Hum Genet. 2019 Feb;138(2):109-124
pubmed: 30671672
J Biomed Opt. 2010 Jul-Aug;15(4):046026
pubmed: 20799828
Breast Cancer Res. 2020 Dec 4;22(1):137
pubmed: 33276807
Int J Med Inform. 2020 Sep;141:104173
pubmed: 32531725
Nat Biotechnol. 2018 Nov;36(10):983-987
pubmed: 30247488
IEEE Trans Biomed Eng. 2010 Jun;57(6):1420-9
pubmed: 20172790
Physiol Genomics. 2018 Apr 1;50(4):237-243
pubmed: 29373082
Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:5513-6
pubmed: 18003260